发明名称 |
Pharmaceutical composition for treating cancer |
摘要 |
The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. Mycobacterium w is administered to mammals suffering from desmocollin-3 expressing cancers. The administration of 6 Mycobacterium w results in control of tumor and improvement in survival. Mycobacterium w can also be used along with other therapeutic agent(s) / modalities as per the requirement. The squamous type of non small cell lung cancer is known to 9 be desmocollin-3 expressing cancer. Other cancers also express desmocollin-3. |
申请公布号 |
AU2012206322(A1) |
申请公布日期 |
2013.08.29 |
申请号 |
AU20120206322 |
申请日期 |
2012.01.10 |
申请人 |
CADILA PHARMACEUTICALS LIMITED |
发明人 |
KHAMAR, BAKULESH MAFATLAL;MODI, INDRAVADAN AMBALAL |
分类号 |
A61K35/74;A61K39/04;A61P35/00 |
主分类号 |
A61K35/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|